Idiopathic bilateral striopallidodentate calcification or Fahr's disease is a degenerative disease normally found in the 5-6 th decade of life. Here we report one of the youngest cases of sporadic Fahr's disease presenting at five years of age with minimal clinical features but extensive intracranial calcification, a rarity.
Introduction
I diopathic bilateral striopallidodentate calcifi cation or Fahr's disease is a degenerative disease normally found in the [5] [6] th decade of life with autosomal dominant inheritance 1, 2, 3, 4 . Few sporadic cases are reported. Here we report one of the youngest cases of sporadic Fahr's disease presenting at fi ve years of age with minimal clinical features but extensive intracranial calcifi cation, a rarity.
Fahr's disease was the diagnosis of exclusion 1, 4, 5 based on clinical, biochemical, and radiological features, ruling out the more common causes of intracranial calcifi cation in children. Symptomatic management was done and the child is currently on follow up. Extensive intracranial calcifi cation is rare in children and needs proper investigation to fi nd out the cause to guide management.
The Case
A 5yr old girl reported in our OPD with the chief complains of brief episodes of convulsion involving the whole body for one week. There was no history of associated fever, trauma, abnormal behaviour, weakness, abnormal movement, unusual colour or odour of urine, bleeding manifestation, jaundice. No signifi cant past history. She was born out of a nonconsanguinous marriage with uneventful antenatal, perinatal and postnatal period. She had achieved normal developmental milestones. Her parents and younger sibling were asymptomatic.The history was classical of generalised tonic clonic convulsion of epilepsy.
General survey revealed normal facies and anthropometric parameters. No neurocutaneous markers. Neurological examination showed no meningeal signs or signs of raised intracranial tension. Higher function, speech, cranial nerves were normal. There was no neurodefi cit, paraesthesias, extrapyramidal symptoms or gait disturbances. Examination of all other systems was normal. CECT scan and EEG were ordered in line with the diagnosis of epilepsy. EEG showed suppression burst pattern. CECT showed bilaterally symmetrical non enhancing hyperdense lesions involving subcortical and periventricular white matter, basal ganglia, white matter of cerebellum, consistent with calcifi cation.
Serum calcium, albumin, phosphorus, alkaline phosphatase and parathormone levels were normal ruling out hypoparathyroidism, pseudohypoparathyroidism, hyperparathyroidism. History and examination ruled out hypocalcemia or hypercalcemia. CT scan of parents and younger sibling were normal.
The child was diagnosed as a sporadic case of fahr's disease and managed symptomatically with antiepileptics. She's on follow up for the last 6 mnths, seizures have been controlled and there are no new symptoms. The younger sibling is also asked to have regular follow ups.
Discussion
The important causes of intracranial calcifi cation are metastatic calcifi cation as in hypoparathyroidism, pseudohypoparathyroidism,hyperparathyroidism, dihydropteridine defi ciency 6 . Dystrophic calcifi cation seen in following encephalitis,TORCH infection parasitosis, ischaemic or haemorrhagic stroke, A-Vmalformations, tumours, phakomatoses, MELAS and Fahr's disease 5, 6 .
There was no history suggestive of stroke or encephalitis. Clinical examination and biochemical parameters ruled out hypo or hypercalcemia, MELAS. Clinical and radiological features were inconsistent with tumours, neurocysticercosis, TORCH infection, A-V malformations, phakomatoses. Thus Fahrs disease was the diagnosis of exclusion 1,4,5 .
Fahr's disease is a rare, genetically dominant, inherited neurological disorder characterized by abnormal deposits of calcium in areas of the brain that control movement, including the basal ganglia and the cerebral cortex. However sporadic 1, 4 cases have been reported, Our case was one such.
The calcium deposits in the brain may occur before the onset of the symptoms, usually in the third decade of life. Although it may also be evident in childhood 4, 5 and with advancing age the amount of calcifi cation increases. In Fahr's disease the mineral deposits tend to be selective for small capillaries and small vessels of white matter, which is diff erent from that in atherosclerosis 4 . The calcifi cation may include endothelial and stromal vascular cells as well as the interstitium. However, the local circulatory disturbances such as regional ischemia have been regarded as the primary event precipitating the deposition of calcium as well as other minerals. Other contributed factors are abnormality in the calcium metabolism or local infl ammatory process 4, 5 . Also, the calcifi cation could be a primary event occurring without preceding circulatory dysfunction, since a signifi cant familial type suggests either autosomal recessive or dominant inheritance 1, 4 . Brain calcifi cation without symptoms such as the small calcifi cations in the basal ganglia, and less commonly in the dentate nucleus of the cerebellum can occur in elderly patients but is of rare occurrence in children.
Symptoms of the disorder may include deterioration of motor function, dementia, seizures, headache, dysarthria (poorly articulated speech), spasticity (stiff ness of the limbs) and spastic paralysis, eye impairments, and athetosis (involuntary, writhing movements) 1,4,5 . Fahr's disease can also include symptoms characteristic of Parkinson's disease such as tremors, muscle rigidity, a mask-like facial appearance, shuffl ing gait, and a "pill-rolling" motion of the fi ngers. These symptoms generally occur later in the development of the disease. More common symptoms include dystonia (disordered muscle tone) and chorea (involuntary, rapid, jerky movements). Age of onset is typically in the 40s or 50s, although it can occur at any time in childhood or There is no cure for Fahr's Syndrome, nor is there a standard course of treatment. Treatment addresses symptoms on an individual basis. Our case has been eff ectively treated with sodium valproate and is on follow up.
The prognosis for any individual with Fahr's disease is variable and hard to predict. There is no reliable correlation between age, extent of calcium deposits in the brain, and neurological defi cit. Since the appearance of calcifi cation is age-dependent, a CT scan could be negative in a gene carrier who is younger than the age of 55 2, 3 . Genetic analysis could not be done due to lack of facility for the same in our set up. Idiopathic Fahr's disease has been linked to IBGC1 locus on chromosome 14q in some cases 2, 3 . However research is needed to understand the actions of the genes involved in this disorder. Finding these could lead to eff ective ways to treat and prevent Fahr's disease.
